# Artiva Biotherapeutics, Inc. (ARTV) - Q2 2026 earnings

Reported August 6, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | Not available |
| EPS | $-0.63 | $-0.63 |

Earnings filing reader: [8-K 0001193125-26-337986](https://www.opencapital.sh/filings/0001193125-26-337986)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-337986.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1817241/000119312526337986/0001193125-26-337986-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1817241/000119312526338029/0001193125-26-338029-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/artv/earnings/q2-2026